Gene Express Appoints Colette Saccomanno, Ph.D. Director of Business Development
13th Nov 2006, 19:52 GMT
Gene Express, Inc. today announced the appointment of Colette Saccomanno, Ph.D. as Director of Business Development. Gerald...
Gene Express Appoints Colette Saccomanno, Ph.D. Director of Business Development related news:
- Gene Express, Inc.: Gene Express Appoints Colette Saccomanno, Ph.D. Director of Business Development — Market Wire - Management Changes
- Ben Franklin Technology Partners of Southeastern Pennsylvania Appoints Anthony P. Green, Ph.D., Vice President of Regional Technology Initiatives — ArriveNet : Press Releases
- LAWA Appoints David Shuter as the New Deputy Executive Director of Project and Facilities Development Services — ArriveNet : Travel
- Tacere Therapeutics Appoints Vice President, Research and Development — RedOrbit News - Health
- Los Angeles World Airports: LAWA Appoints David Shuter as the New Deputy Executive Director of Project and Facilities Development Services — Market Wire - Transportation and Logistics
- Tacere Therapeutics Appoints VP, R&D — Pharmaceuticals News from StratCenter.com
- Zones, Inc.: Zones Appoints Thomas Lutz as VP Business Development — Market Wire - Computers and Software
- Lynch supports economic development director nomination — Boston.com / News
- Blocking Cancer-Causing Gene Improves Radiation Effectiveness, Jefferson Researchers Find — Health News from Medical News Today
- ACLU Appoints New Director — BYU NewsNet : Utah
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL